The data revealed that the use of the Trans-Arterial Micro-Perfusion (TAMP) device resulted in greater drug potency and fewer ...
Presented as part of the ASCO Gastrointestinal Cancers Symposium (ASCO GI) 2025 in San Francisco, pharmacokinetic (PK) data found that drug delivery via the company’s TAMP system decreased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results